Daxor Corporation (DXR) DCF Valuation

Daxor Corporation (DXR) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Daxor Corporation (DXR) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Looking to assess the intrinsic value of Daxor Corporation? Our DXR DCF Calculator integrates real-world data with comprehensive customization features, allowing you to refine your forecasts and enhance your investment choices.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue -.1 -1.0 5.8 6.3 1.3 1.1 .9 .7 .6 .5
Revenue Growth, % 0 766.41 -684.28 8.4 -79.71 -17.83 -17.83 -17.83 -17.83 -17.83
EBITDA -.5 -1.7 4.7 5.3 .3 .8 .7 .6 .5 .4
EBITDA, % 431.07 172.87 81.57 83.21 25.75 78.1 78.1 78.1 78.1 78.1
Depreciation .0 .3 .7 .9 .5 .1 .1 .1 .1 .0
Depreciation, % 18.64 -33.92 12.81 13.62 39.58 10.15 10.15 10.15 10.15 10.15
EBIT -.5 -2.1 4.0 4.4 -.2 .7 .6 .5 .4 .3
EBIT, % 412.43 206.79 68.76 69.58 -13.83 64.9 64.9 64.9 64.9 64.9
Total Cash .0 .6 .7 .0 .0 -.1 -.1 -.1 -.1 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % -28.47 -2.94 0.52738 0.27309 1.11
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 0 0 0 0 0 0 0 0 0
Accounts Payable .1 .1 .1 .1 .0 -.2 -.1 -.1 -.1 -.1
Accounts Payable, % -68.48 -8.03 1.5 0.98943 0 -14.8 -14.8 -14.8 -14.8 -14.8
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 0 0 0 0 0 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -.5 -2.0 4.0 4.4 -.2 .7 .6 .5 .4 .3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -.4 -1.7 4.8 5.2 .3 .7 .7 .5 .4 .4
WACC, % 5.42 5.41 5.42 5.42 5.42 5.42 5.42 5.42 5.42 5.42
PV UFCF
SUM PV UFCF 2.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 11
Present Terminal Value 8
Enterprise Value 11
Net Debt 1
Equity Value 10
Diluted Shares Outstanding, MM 5
Equity Value Per Share 2.18

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real DXR financials.
  • Real-World Data: Historical data and forward-looking estimates (as highlighted in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe how your inputs affect Daxor Corporation’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • 🔍 Real-Life DXR Financials: Pre-filled historical and projected data for Daxor Corporation (DXR).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Daxor’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Daxor’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Daxor Corporation’s (DXR) data.
  • Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including Daxor Corporation’s (DXR) intrinsic value.
  • Step 5: Utilize the outputs to make informed investment decisions or generate detailed reports.

Why Choose Daxor Corporation (DXR)?

  • Innovative Solutions: Benefit from cutting-edge technology tailored for the healthcare industry.
  • Proven Results: Our products have consistently demonstrated improved patient outcomes.
  • Expert Support: Access to a dedicated team of professionals ready to assist you.
  • Comprehensive Data: Leverage extensive research and analytics to inform your decisions.
  • Industry Leader: Trusted by healthcare providers and institutions worldwide.

Who Should Use Daxor Corporation (DXR)?

  • Healthcare Professionals: Understand the implications of blood volume measurement and its impact on patient care.
  • Researchers: Integrate advanced blood volume analysis into clinical studies or academic projects.
  • Investors: Evaluate the potential of Daxor Corporation (DXR) by analyzing market trends and company performance.
  • Medical Analysts: Enhance your analysis with a comprehensive understanding of Daxor's innovative technologies.
  • Hospital Administrators: Discover how Daxor's solutions can improve operational efficiencies and patient outcomes.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Daxor Corporation (DXR) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Daxor Corporation (DXR).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

Es wurden keine passenden Produkte gefunden.